2020
DOI: 10.1007/s10557-020-07013-w
|View full text |Cite
|
Sign up to set email alerts
|

Dipeptidyl Peptidase-4 Inhibitor Decreases Allograft Vasculopathy Via Regulating the Functions of Endothelial Progenitor Cells in Normoglycemic Rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 10 publications
(5 citation statements)
references
References 49 publications
0
5
0
Order By: Relevance
“…In this study, although we only explored the effects of PAW on OAT-induced vasculopathy and obtained surprising results, we continue to study its detailed mechanism of action. Previous, we have demonstrated that dipeptidyl peptidase-4 (DPP-4) inhibitor lowers OAT vasculopathy in rats through direct increase in GLP-1 activity, and regulates SDF-1α levels and EPCs function [ 69 ]. We are the first group to provide new prevention and treatment strategies for DPP-4 inhibitors in chronic rejection-induced vasculopathy.…”
Section: Discussionmentioning
confidence: 99%
“…In this study, although we only explored the effects of PAW on OAT-induced vasculopathy and obtained surprising results, we continue to study its detailed mechanism of action. Previous, we have demonstrated that dipeptidyl peptidase-4 (DPP-4) inhibitor lowers OAT vasculopathy in rats through direct increase in GLP-1 activity, and regulates SDF-1α levels and EPCs function [ 69 ]. We are the first group to provide new prevention and treatment strategies for DPP-4 inhibitors in chronic rejection-induced vasculopathy.…”
Section: Discussionmentioning
confidence: 99%
“…The allograft OAT procedure has been demonstrated in a previous study. 25 For XTP, approximately 1 cm of the ScCO 2 -DFA or SDS-DFA was anatomized with 7-O silk sutures onto the abdominal aorta of ACI/NKyo rats. The OAT and XTP procedures were completed within 80 min.…”
Section: Methodsmentioning
confidence: 99%
“…However, aortic transplantation in the PVG/Seac rats to ACI/NKyo rats model is more appropriate for studies regarding chronic rejection-induced allograft vasculopathy as the ACI/NKyo rat develops a weak acute rejection response against the graft aorta from the PVG/Seac rat. Lin et al transplanted a thoracic aorta from a PVG/Seac rat to the abdominal aorta of an ACI/NKyo rat to study the endothelial mesenchymal transition as a mechanism that induces CAV and identify treatments for CAV by monitoring cell-cell interactions [25][26][27]. In addition, the authors used this method to investigate molecular pathways that may have protective effects against chronically-rejected grafts [27].…”
Section: Heterotopic Aortic Transplantation In Ratsmentioning
confidence: 99%